Inhibitors and Inactivators of Protein Arginine Deiminase 4: Functional and Structural Characterization,
Citations Over TimeTop 10% of 2006 papers
Abstract
Protein arginine deiminase 4 (PAD4) is a transcriptional coregulator that catalyzes the calcium-dependent conversion of specific arginine residues in proteins to citrulline. Recently, we reported the synthesis and characterization of F-amidine, a potent and bioavailable irreversible inactivator of PAD4. Herein, we report our efforts to identify the steric and leaving group requirements for F-amidine-induced PAD4 inactivation, the structure of the PAD4-F-amidine x calcium complex, and in vivo studies with N-alpha-benzoyl-N5-(2-chloro-1-iminoethyl)-L-ornithine amide (Cl-amidine), a PAD4 inactivator with enhanced potency. The PAD4 inactivators described herein will be useful pharmacological probes in characterizing the incompletely defined physiological role(s) of this enzyme. In addition, they represent potential lead compounds for the treatment of rheumatoid arthritis because a growing body of evidence supports a role for PAD4 in the onset and progression of this chronic autoimmune disorder.
Related Papers
- → Citrullination: a small change for a protein with great consequences for rheumatoid arthritis.(2000)237 cited
- → Pitfalls in the detection of citrullination and carbamylation(2017)46 cited
- → Citrullination: A modification important in the pathogenesis of autoimmune diseases(2022)21 cited
- → Boron-Assisted Selective Citrulline Modification under Mild Conditions(2022)2 cited
- Citrullination, the spark that ignites the fire in rheumatoid arthritis?(2004)